RedHill Biopharma Ltd.
RDHL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,268 | $23,916 | -$71,669 | -$97,744 |
| Dep. & Amort. | $619 | $1,990 | $8,154 | $18,149 |
| Deferred Tax | $0 | $0 | $0 | $123 |
| Stock-Based Comp. | $665 | $1,647 | $5,675 | $10,212 |
| Change in WC | $2,053 | -$15,579 | $8,008 | -$1,153 |
| Other Non-Cash | -$4,438 | -$47,794 | $20,647 | $5,366 |
| Operating Cash Flow | -$9,369 | -$35,820 | -$29,185 | -$65,047 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$11 | -$198 | -$115 |
| Net Acquisitions | $0 | $0 | $0 | $8,025 |
| Inv. Purchases | $0 | $0 | $0 | -$8,500 |
| Inv. Sales/Matur. | $0 | $15 | $8,500 | $475 |
| Other Inv. Act. | $0 | $0 | $0 | -$8,025 |
| Investing Cash Flow | -$9 | $4 | $8,302 | -$8,140 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$636 | -$1,175 | -$1,475 | -$1,683 |
| Stock Issued | $8,263 | $13,959 | $23,806 | $78,536 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $790 | $8,600 | -$10,878 | -$3,391 |
| Financing Cash Flow | $8,417 | $21,384 | $11,453 | $73,462 |
| Forex Effect | $9 | -$22 | -$76 | -$96 |
| Net Chg. in Cash | -$952 | -$14,399 | -$9,506 | $179 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,569 | $19,968 | $29,474 | $29,295 |
| End Cash | $4,617 | $5,569 | $19,968 | $29,474 |
| Free Cash Flow | -$9,378 | -$35,831 | -$29,383 | -$65,162 |